|
|
| Research article summary (published 30 Dec 2004): |
Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis.
Full Abstract
The life-long interdependencies/interactions between hemato- and endotheliopoiesis suggest that they form a supplementary functional entity. This view is compatible with the concept of stem cell plasticity as a reversible continuum and is substantiated by the common hematopoietic-endothelial stem cell, i.e., hemangioblasts, with bidirectional, reversible gene transcription and persistence in postnatal life. Indeed, embryonal stem cells/hemangioblasts appear to form a reservior in the adult with the possibility of dedifferentiation of more differentiated progenitor cells back to hemangioblasts. The recent detection of BCR/ABL fusion proteins in endothelial cells during vascular neoangiogenesis in CML suggests that endothelial cells are part of the neoplastic clone, and extends the concept of a functional entity to include CML angiogenesis. Thus, hemangioblasts rather than committed hematopoietic stem cells appear to be target cells for the first oncogenic hit in CML, which could occur as early as during the first steps of embryonal stem cell differentiation towards hemato-endotheliopoiesis and/or in hemangioblasts persisting in adults. The relation of the other leukemias to hemangioblasts is not known.
Author information
Author/s: Prindull, Gregor (G);
Affiliation: Pediatric Hematology/Oncology, University of Göttingen, Germany. Gregorprindull(-atsign-)aol.com
Journal and publication information
Publication Type: Journal Article; Review
Journal: Stem cell reviews (Stem Cell Rev), published in United States. (Language: eng)
Reference: 2005-; vol 1 (issue 3) : pp 277-84
Dates: Created 2006/12/04; Completed 2007/01/23; Revised 2007/11/15;
PMID: 17142866, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Fusion Proteins, bcr-abl (0)Related articles
These are the most related articles currently in our database:
- Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cells.
30 Aug 1990 - Hematopoietic stem cells, leukemic stem cells and chronic myelogenous leukemia.
18 Feb 2005 - Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative.
6 May 2008 - Stem cell kinetics.
30 May 1997 - P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation.
30 Jul 1996 - Clinical heterogeneity in chronic myeloid leukaemia reflecting biological diversity in normal persons.
30 Jul 2003 - PML targeting eradicates quiescent leukaemia-initiating cells.
9 May 2008 - Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors.
27 Feb 1995 - The biology of normal and neoplastic stem cells in CML.
30 Dec 1992 - Chronic myeloid leukemia stem cells.
8 Jun 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.